Features
China Pumps Up The Panda Bond Market
With interest rates rising in the West, China hopes its falling interest rates will attractmultinationals to its domestic bond market.
Author: Craig Mellow
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click Here
Banking
The Big-Bank Comeback
Banks, challenged lately by macro and digital trends, are stronger now.
Sustainable Finance
Commodity Storm
War and weather highlight the vulnerability of supplies critical to humanity’s future—especially food staples and the metals for renewable energy.
Capital Raising & Corporate Finance
Setting A Minimum
As of next year, every corporation may have to begin paying at least 15% in corporate taxes, regardless of which country it calls home.
Banking
Sanctions And The Dollar
The West’s financial assault on Russia may strengthen the yuan and cryptocurrency, but slowly.
News
China Won’t Ride To Russia’s Rescue
The war in Ukraine is undermining the increasingly close partnership between Russia and China.
Features
Private Banking: Demanding Times For ESG
The wealthy are ready for a more sustainable future, but struggling with just how to get there.
Sustainable Finance
Carbon Trading 2.0
The effect of the Glasgow COP26 meeting continues to grow and is now propelling the carbon-trading market.
Awards
World’s Best Private Banks 2022
Private banking has been tested by nearly two years of the Covid-19 pandemic. The industry passed with flying colors—and with considerable help from buoyant financial markets.
Capital Raising & Corporate Finance
The Challenge Of DeFi
Decentralizing finance can unlock capital in cryptocurrencies, but will it last?
Banking
Womens Wealth Grows, Private Banks Respond
Top banks narrow the gender gap to better serve all investors.
News
Combining Powers: Q&A With GSK Consumer Healthcare’s Bjarne Tellmann
Bjarne Tellmann is senior vice president and general counsel at GSK Consumer Healthcare, a joint venture that combines the consumer brands of GSK and Pfizer. He speaks to Global Finance about the intersectionality of his work.